Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,386,974 papers from all fields of science
Search
Sign In
Create Free Account
GOSR2 gene
Known as:
Bos1
, GOSR2
, MEMBRIN
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
G-T haplotype established by rs3785889-rs16941382 in GOSR2 gene is associated with coronary artery disease in Chinese Han population.
S. Pan
,
G. Guan
,
+9 authors
Junkui Wang
OncoTarget
2017
Corpus ID: 6578568
OBJECTIVES The aim of the present study is to assess the association between the human GOSR2 gene and coronary artery disease…
Expand
2017
2017
G-T haplotype established by rs3785889-rs16941382 in GOSR2 gene is associated with coronary artery disease in Chinese Han population
S. Pan
,
G. Guan
,
+9 authors
Junkui Wang
OncoTarget
2017
Corpus ID: 54469217
Objectives The aim of the present study is to assess the association between the human GOSR2 gene and coronary artery disease…
Expand
2015
2015
p115–SNARE Interactions: A Dynamic Cycle of p115 Binding Monomeric SNARE Motifs and Releasing Assembled Bundles
Ting Wang
,
R. Grabski
,
E. Sztul
,
J. Hay
Traffic : the International Journal of…
2015
Corpus ID: 40931027
Tethering factors regulate the targeting of membrane‐enclosed vesicles under the control of Rab GTPases. p115, a golgin family…
Expand
2013
2013
P.2.1 The NorthStar Ambulatory Assessment in Duchenne Muscular Dystrophy: Considerations for the design of clinical trials
V. Ricotti
,
D. Ridout
,
+4 authors
F. Muntoni
Neuromuscular Disorders
2013
Corpus ID: 54403929
2005
2005
Evidence for regulation of ER/Golgi SNARE complex formation by hsc70 chaperones.
A. Joglekar
,
J. Hay
European Journal of Cell Biology
2005
Corpus ID: 36087140
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE